DocDollars

Carl Zeiss Meditec, Inc.

CA · United States · Reporting entity ID 100000005433

Total reported 2019–2025
$18.2M
#345 of 2,960 reporting companies — 0% of all reported industry payments
$12.2M in general payments across 14,982 records, plus $6.02M in research funding across 344 records.

How it breaks down

General payments $12,209,364
Research funding $6,021,334

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Carl Zeiss Meditec, Inc. reported $18.2M to US doctors and teaching hospitals from 2019 to 2025, ranking #345 of 2,960 reporting companies. 33% of that was research funding and 67% general payments such as consulting, speaking, food and travel. 14,982 general payment records and 344 research records were filed.

Common questions about Carl Zeiss Meditec, Inc.

How much has Carl Zeiss Meditec, Inc. paid US doctors?

Carl Zeiss Meditec, Inc. reported $18,230,698 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $12,209,364 in general payments, $6,021,334 in research funding.

How does Carl Zeiss Meditec, Inc. rank among drug and device companies?

It ranks #345 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Carl Zeiss Meditec, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.